AstraZeneca stock falls as drugmaker pauses vaccine trial after volunteer’s ‘unexplained illness’
News comes as Britain set to announce new measures to curb the spread of the virus after a sharp rise in cases
We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.